NO952608L - Derivatiserte kalsitoniner - Google Patents

Derivatiserte kalsitoniner

Info

Publication number
NO952608L
NO952608L NO952608A NO952608A NO952608L NO 952608 L NO952608 L NO 952608L NO 952608 A NO952608 A NO 952608A NO 952608 A NO952608 A NO 952608A NO 952608 L NO952608 L NO 952608L
Authority
NO
Norway
Prior art keywords
derivatized
molecules
calcitonins
calcitonin
derivatized calcitonins
Prior art date
Application number
NO952608A
Other languages
English (en)
Norwegian (no)
Other versions
NO952608D0 (no
Inventor
Virender M Labroo
Tomikazu Sasaki
Original Assignee
Zymogenetics Inc
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc, Univ Washington filed Critical Zymogenetics Inc
Publication of NO952608D0 publication Critical patent/NO952608D0/no
Publication of NO952608L publication Critical patent/NO952608L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57527—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO952608A 1992-12-31 1995-06-29 Derivatiserte kalsitoniner NO952608L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99974992A 1992-12-31 1992-12-31
PCT/US1993/012692 WO1994015962A2 (en) 1992-12-31 1993-12-30 Derivatized calcitonins

Publications (2)

Publication Number Publication Date
NO952608D0 NO952608D0 (no) 1995-06-29
NO952608L true NO952608L (no) 1995-08-30

Family

ID=25546645

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952608A NO952608L (no) 1992-12-31 1995-06-29 Derivatiserte kalsitoniner

Country Status (9)

Country Link
EP (1) EP0677062A1 (ja)
JP (1) JPH08505393A (ja)
KR (1) KR100310280B1 (ja)
AU (1) AU673237B2 (ja)
CA (1) CA2153071C (ja)
FI (1) FI953255A (ja)
NO (1) NO952608L (ja)
NZ (1) NZ261052A (ja)
WO (1) WO1994015962A2 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962270A (en) 1996-02-06 1999-10-05 Bionebraska, Inc. Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1806135A1 (de) * 1967-11-09 1969-07-17 Ciba Geigy Neue hypocalcaemische Peptide und Verfahren zu ihrer Herstellung
US3956260A (en) * 1967-11-09 1976-05-11 Ciba-Geigy Corporation Hypocalcaemic peptides and processes for their manufacture
CH523868A (de) * 1969-10-22 1972-06-15 Ciba Geigy Ag Verfahren zur Herstellung neuer Dotriacontapeptidamide und ihrer Derivate
HUT44794A (en) * 1985-12-04 1988-04-28 Sandoz Ag Process for production of calcitonine-derivatives and medical preparatives containing such compounds
EP0297159A1 (en) * 1987-07-01 1989-01-04 Armour Pharmaceutical Company [N-Acyl, 1,7-Di-Aline] calcitonins, method for their preparation, pharmaceutical compositions and use
DE3876022T2 (de) * 1987-07-08 1993-04-22 Mitsubishi Petrochemical Co Calcitonin-derivate und deren salze.

Also Published As

Publication number Publication date
FI953255A0 (fi) 1995-06-30
FI953255A (fi) 1995-06-30
WO1994015962A2 (en) 1994-07-21
JPH08505393A (ja) 1996-06-11
AU5962994A (en) 1994-08-15
AU673237B2 (en) 1996-10-31
WO1994015962A3 (en) 1994-09-29
CA2153071A1 (en) 1994-07-21
KR100310280B1 (ko) 2002-02-28
NO952608D0 (no) 1995-06-29
EP0677062A1 (en) 1995-10-18
NZ261052A (en) 1997-10-24
CA2153071C (en) 2000-05-30
KR960700273A (ko) 1996-01-19

Similar Documents

Publication Publication Date Title
ES2174855T3 (es) Metodos diagnosticos y composiciones farmaceuticas que se basan en proteinas notch y acidos nucleicos.
AU4162400A (en) Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii
PT946191E (pt) Uso de analogos e derivados de glp-1 administradosperifericamente na regulacao da obesidade
NZ504114A (en) Vitamin k-dependent polypeptides such as protein C where substitution at amino acid sites 11, 12, 29, 33 or 34 affects membrane binding affinity of the protein and ultimately blood clotting ability
BG100974A (en) Vaccines against papillomavirus
ATE173478T1 (de) Varianten des pankreatischen rinder- trypsininhibitors, deren herstellung und verwendung
IT1255258B (it) Composizioni farmaceutiche per l'applicazione per via nasale.
NO20061455L (no) 2,6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
DK0831812T3 (da) Fremgangsmåder og præparater til stimulering af neuritvækst
ATE136221T1 (de) Osteo-induktive pharmazeutische formulierungen
NZ512083A (en) Methods of increasing lean tissue mass using OB protein compositions
EE03975B1 (et) Keratinotsüüdi kasvufaktori analoogid
TR199802534T2 (xx) Leptin (OB Protein) fragmanlar�
DE69434384D1 (de) Metalkomplexbildner
DE69836678D1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
DE69117375D1 (de) Neue Piperidylether und -thioether als Inhibitoren der Cholesterol-Biosynthese
AU5092685A (en) A preparation for the treatment of hemophilia a inhibitor patients and a process for producing such a preparation
ATE365542T1 (de) Lyophilisierbare pharmazeutische plazebozusammensetzung , insbesondere auf basis von proteinen oder polypeptiden, zur nachahmung eines arzneimittels
EP0716591A4 (en) METHODS AND COMPOSITIONS FOR FIXING TAU AND MAP2c PROTEINS
NO952608L (no) Derivatiserte kalsitoniner
NZ296765A (en) 8-cyclohexyl substituted xanthine derivatives and medicaments
DK450187D0 (da) Fremgangsmaade til fremstilling af proteiner
KR910700259A (ko) T-세포 인지성 펩티드 변형에 의해 면역반응에 영향을 주는 방법
TR200002611T2 (tr) Beta-lipotropin ve kullanımları
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application